about
One-year brain atrophy evident in healthy agingAutomated white-matter tractography using a probabilistic diffusion tensor atlas: Application to temporal lobe epilepsy.Brain development and aging: overlapping and unique patterns of change.Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairmentCSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Brain changes in older adults at very low risk for Alzheimer's disease.APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age MattersThe role of clusterin in amyloid-β-associated neurodegeneration.Relationship between regional atrophy rates and cognitive decline in mild cognitive impairmentNeuroimaging enrichment strategy for secondary prevention trials in Alzheimer disease.Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.Rates of decline in Alzheimer disease decrease with age.Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease.Enrichment and stratification for predementia Alzheimer disease clinical trials.The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.Nonlinear registration of longitudinal images and measurement of change in regions of interestWhat is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampusShape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.An Empirical Bayes Mixture Model for Effect Size Distributions in Genome-Wide Association StudiesLeveraging Genomic Annotations and Pleiotropic Enrichment for Improved Replication Rates in Schizophrenia GWAS.Characterization and Correction of Geometric Distortions in 814 Diffusion Weighted ImagesAmyloid-β associated volume loss occurs only in the presence of phospho-tau.Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning.Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau.Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.Bias in tensor based morphometry Stat-ROI measures may result in unrealistic power estimates.Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairmentEstimating Effect Sizes and Expected Replication Probabilities from GWAS Summary StatisticsCritical ages in the life course of the adult brain: nonlinear subcortical agingAssociation Between Genetic Traits for Immune-Mediated Diseases and Alzheimer DiseaseStructural growth trajectories and rates of change in the first 3 months of infant brain development.Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI.APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's diseaseHeart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration.
P50
Q24642943-919B0ECA-F0D8-4057-A59A-1EBCD98DD390Q30490655-EF7A04BA-39D6-4258-8E8A-B9A8E07DD2D2Q30843829-A313A765-320F-4334-A854-8D7F8917238CQ30847288-A0AE7E4B-AFA6-489C-A642-8F69609979F4Q30981669-53C6F708-0A9D-49E4-91E1-AEE891805B36Q33406823-EEE3F27F-BD02-4C83-84C5-27FEAF013DD4Q33689474-7208665C-A083-4401-A046-F63D3A66AC8FQ33729050-94987565-077C-4C59-90EF-D3D1A8D49C97Q33822745-172CCDD8-6628-4E14-8D47-909C42F835BBQ33988464-345A8AB4-C434-4E46-8C27-E105B9300A1DQ34073224-EC8181E6-4889-4424-A841-BF019067A02FQ34088600-95BE91E6-FB26-4682-BF02-7484DB43A8DCQ34176310-D141ECF0-C68E-41AF-87D1-43C60FC35C4EQ34372593-3A95C6FA-572C-44C1-AE9F-00D01B4AC903Q34443664-3ACEF3E8-9206-4F43-BDC7-56E2CFE56FA8Q34452239-7E247952-F87E-43F5-BAB8-B8740182D5F6Q34460995-BEC1793B-018E-4B64-B23F-BA8FDAEDB6E2Q34471227-27EB684C-4AB6-45BA-8D5D-8152B00744B1Q34514638-FD525140-BEC5-450F-8D06-85E2E8D014E7Q34746717-CE05B307-3213-4F22-B937-217ED7250A4CQ35009495-3A7F3F0D-5EE7-42C3-B9A6-7ABD03F24B5EQ35046222-DEC5E5BE-D389-4322-8BA0-03B55D47A51FQ35129501-0BEA5572-4745-4ACA-BD96-50708604F577Q35759912-F5320201-E7E8-4E69-9CCD-8932F1DEFC8AQ35880708-0DAEC2E6-7BDF-4226-9B1F-B9A4873E3A27Q35903759-D7871644-1CDE-4F79-8974-E472BC314D69Q35973830-CE6132F1-29B8-45EC-B990-84C3D6D8EA99Q36010484-90173715-17C0-4401-BE76-3CC3688A4176Q36103805-7449B7A7-AC50-4F0F-94B7-46C4BA359326Q36177140-1D083D5A-2DDD-4EA0-B73A-5A298448B1BFQ36316307-9086605B-1566-4F6C-8A19-98FDFB360281Q36319079-CFF79FE4-9595-4F78-B76C-EDA075A2570EQ36368491-9CCB1B03-DC77-403D-83B3-C0B342D20332Q36582532-8AE91F7B-0A74-46D1-83B3-23642D7FA841Q36997071-726CB71F-E7D1-44F6-80F9-35732454F3E4Q36999150-1D80E85C-A43E-482E-BB3C-78FCBA1413DAQ37083232-9A333785-575B-41BB-A44B-84CEFE334953Q37195596-779F3C1B-5449-4D2F-8CA1-CBED6E088EB9Q37274460-6316C4A1-E1EC-4746-AE12-26D71E5FC84CQ37363347-78CC9B8B-812F-40CA-B108-C39622BC6F12
P50
name
Dominic Holland
@ast
Dominic Holland
@en
Dominic Holland
@nl
type
label
Dominic Holland
@ast
Dominic Holland
@en
Dominic Holland
@nl
prefLabel
Dominic Holland
@ast
Dominic Holland
@en
Dominic Holland
@nl